Apricity, 30 Rue Fortuny, Paris 75017, France; Institute of Reproduction and Developmental Biology, Imperial College London, London, UK; TMRW Life Sciences, 250 Hudson St. Suite 701, New York, NY, USA.
GENNET City Fertility, 16 St John Street, London EC1M 4NT, UK.
Reprod Biomed Online. 2020 Aug;41(2):141-150. doi: 10.1016/j.rbmo.2020.05.006. Epub 2020 May 21.
Fertility societies worldwide responded to the COVID-19 pandemic by recommending that fertility clinics close, or sharply reduce, the clinical operation, leading to a shift in the management of IVF laboratories in three phases: shutdown preparation; maintenance during shutdown; and restart. Each of these phases carries distinct risks that need identification and mitigation, forcing laboratory managers to rethink and adapt their procedures in response to the pandemic. The sudden and unprecedented nature of the pandemic forced laboratory managers from around the world to base decisions on opinion and experience when evidence-based response options were unavailable. These perspectives on pandemic response were presented during a virtual international symposium on COVID-19, held on 3 April 2020, and organized by the London Laboratory Managers' Group. Laboratory managers from seven different countries at different stages of the pandemic (China, Italy, Spain, France, UK, Brazil and Australia) presented their personal experiences to a select audience of experienced laboratory managers from 19 different countries. The intention of this paper is to collect the learnings and considerations from this group of laboratory managers who collaborated to share personal experiences to contribute to the debate surrounding what constitutes good IVF laboratory practice in extraordinary circumstances, such as the COVID-19 pandemic.
全球生育协会针对 COVID-19 疫情的反应是建议生育诊所关闭或大幅减少临床运作,导致 IVF 实验室的管理分三个阶段发生转变:关闭准备阶段、关闭期间的维持阶段和重新启动阶段。这些阶段都有独特的风险,需要识别和缓解,迫使实验室经理重新思考并调整他们的程序以应对疫情。疫情的突然性和前所未有的性质迫使来自世界各地的实验室经理在没有基于证据的应对方案时,基于意见和经验做出决策。在 2020 年 4 月 3 日举行的一场关于 COVID-19 的虚拟国际研讨会上提出了这些关于疫情应对的观点,该研讨会由伦敦实验室经理小组组织。来自不同国家的实验室经理在疫情的不同阶段(中国、意大利、西班牙、法国、英国、巴西和澳大利亚)向一个由来自 19 个不同国家的经验丰富的实验室经理组成的精选观众介绍了他们的个人经验。本文的目的是收集来自这群合作分享个人经验的实验室经理的经验教训和考虑因素,为在 COVID-19 等特殊情况下构成良好 IVF 实验室实践的辩论做出贡献。